ID2 and TCF4

  • Number of citations of the paper that reports this interaction (PMID 9242638)
  • 48
  • Data Source:
  • HPRD (in vivo, two hybrid)

ID2

TCF4

Gene Name inhibitor of DNA binding 2, dominant negative helix-loop-helix protein transcription factor 4
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 37 interactors: ADD1 ASB4 CDK2 ELK1 ELK3 ELK4 GATA4 HES1 HSPA5 IFI16 KDM1A LRIF1 MAPK1 MAPK3 MAPK8 MSC MYF5 MYF6 MYOD1 MYOG NEDD9 PAX2 PAX5 PAX8 PPP1CA PRMT6 RB1 RBL1 RBL2 RBM48 SUV39H1 SUV39H2 TCF12 TCF3 TCF4 TSTA3 UNC119 173 interactors: AES AQP1 AR ARHGEF1 ARMC7 ASCL1 ASCL3 ASCL4 ASPSCR1 ATP6V1B2 BCAS2 BCL2L2 BZRAP1 C19orf66 C1orf109 C9orf171 CABP5 CALM1 CALM2 CALM3 CCDC101 CDC73 CDKN1A CDKN2C CHAF1A CHCHD2 CHIC2 CKS1B CTBP1 CTNNB1 DDX6 DEF6 DGCR6 DMRT3 EFHC1 EIF4E2 EIF4EBP1 EP300 EPB41L3 EPHB6 EXOSC1 FAH FAM124B FAM74A4 FERD3L FLAD1 FLNA FRS3 GEM GLRX3 GNG10 GOLGA8EP GOLGA8F GORASP2 GTF3C5 GUCD1 HAND2 HAT1 HBP1 HIC1 HSPB7 ID1 ID2 ID3 ID4 INS JUN JUP KCTD14 KLC3 KLHL32 LASP1 LENG1 LGALS14 LMO1 LMO4 LNPEP LYL1 MAD2L2 MAGOHB MAPKBP1 MATN3 MEMO1 MEN1 MLLT6 MORN4 MRFAP1L1 MRPL10 MSC MSRB3 MVP MYO5B MYOD1 NCK2 NDOR1 NEK6 NEK8 NEU4 NEUROD1 NEUROG1 NME7 NMUR2 NOL9 NR2C2AP NR4A1 NUDT10 ORC4 OSGIN1 OTUD4 PARK2 PARP1 PATE1 PBLD PIN1 PLEKHN1 POLR1A POLR1C PPIA PPIL1 PPP1R18 PRKAA2 PRKAB2 PSEN1 PSMA1 PSMG2 PTF1A PTGER3 RAB41 RABIF RECK RELA REXO1L6P RNF138 RSPH14 RUNX1T1 SCOC SEC14L4 SIGLEC6 SLC39A13 SLC4A1AP SMCP SMOC1 SPATC1L SPG21 SRSF2 STAMBPL1 STK16 STX11 SUMO1 SZT2 TAL1 TAL2 TAPBPL TCEA2 TCF3 TCL1A TLE1 TMEM213 TRAPPC2L TSSC4 TSSK3 TWIST2 TXNL4B USP4 UTP23 VPS28 XRCC5 XRCC6 ZDHHC24 ZNF124 ZNF205-AS1 ZNF417 ZNF587
Entrez ID 3398 6925
HPRD ID 02664 03780
Ensembl ID ENSG00000115738 ENSG00000196628
Uniprot IDs Q02363 Q53T66 B3KVA4 E9PH57 H3BTP3 P15884
PDB IDs 4AYA 2KWF
Enriched GO Terms of Interacting Partners?
Tagcloud ?
basic  bhlh  blackfan  broadly  compensated  competed  dba  declined  defect  diamond  disrupted  downregulate  e47  enhancing  erythroblasts  erythroid  globin  heb  helix  heterodimer  maturation  positively  precursors  progenitors  scf  scl  sequesters  stimulates  transfusion 
action  activities  agent  beta  biejiajian  catenin  cultured  cyclin  cytoplasmic  d1  downstream  expressions  fed  hepatocellular  hepg2  immunofluorescence  inhibiting  invasiveness  lowered  luciferase  mmp  pills  qrt  sera  serve  suppress  underlying  whose  wnt 
Tagcloud (Difference) ?
basic  bhlh  blackfan  broadly  compensated  competed  dba  declined  defect  diamond  disrupted  downregulate  e47  enhancing  erythroblasts  erythroid  globin  heb  helix  heterodimer  maturation  positively  precursors  progenitors  scf  scl  sequesters  stimulates  transfusion 
action  activities  agent  beta  biejiajian  catenin  cultured  cyclin  cytoplasmic  d1  downstream  expressions  fed  hepatocellular  hepg2  immunofluorescence  inhibiting  invasiveness  lowered  luciferase  mmp  pills  qrt  sera  serve  suppress  underlying  whose  wnt 
Tagcloud (Intersection) ?